However, this brand is approved for type 2 diabetes, not as a chronic weight-management medicine
no therapeutic claims are made
Diltiazem Co-administration of diltiazem hydrochloride extended-release with topiramate (150 mg/day) resulted in a 10% decrease in C max and a 25% decrease in diltiazem AUC, a 27% decrease in C max and an 18% decrease in des-acetyl diltiazem AUC, and no effect on N-desmethyl diltiazem
P.Dcct/Edic Research Group
Hindawi Limited Liang L, Su X, Guan Y, Wu B, Zhang X, Nian X (2024) Correlation between intestinal flora and GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatmentA preliminary longitudinal study
What is the current compounding ban on semaglutide